SGI
BIIB icon

Summit Global Investments’s Biogen BIIB Stock Holding History

Summit Global Investments’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-962
Closed -$223K – 509
2024
Q2 		$223K Buy
+962
New +$209K 0.02% 461
2024
Q1 		– Sell
-6,088
Closed -$1.57M – 506
2023
Q4 		$1.57M Buy
+6,088
New +$1.5M 0.1% 148
2021
Q2 		– Sell
-5,950
Closed -$1.67M – 565
2021
Q1 		$1.67M Buy
+5,950
New +$1.6M 0.11% 147
2020
Q4 		– Sell
-7,000
Closed -$1.99M – 258
2020
Q3 		$1.99M Buy
7,000
+5,849
+508% +$1.63M 0.21% 74
2020
Q2 		$308K Buy
1,151
+294
+34% +$88.4K 0.04% 215
2020
Q1 		$271K Sell
857
-58
-6% -$17.6K 0.04% 204
2019
Q4 		$272K Buy
+915
New +$254K 0.03% 261
2019
Q3 		– Sell
-897
Closed -$210K – 269
2019
Q2 		$210K Sell
897
-52
-5% -$12K 0.03% 277
2019
Q1 		$224K Buy
949
+16
+2% +$5.04K 0.03% 269
2018
Q4 		$281K Sell
933
-5,039
-84% -$1.61M 0.04% 240
2018
Q3 		$2.11M Sell
5,972
-110
-2% -$37.9K 0.28% 78
2018
Q2 		$1.76M Sell
6,082
-18,248
-75% -$5.13M 0.27% 79
2018
Q1 		$6.66M Sell
24,330
-5,663
-19% -$1.76M 1.06% 33
2017
Q4 		$9.55M Buy
+29,993
New +$9.62M 1.48% 21

Other funds holding BIIB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Summit Global Investments's BIIB Position: Q3 2024 in Review

Summit Global Investments sold out of Biogen (BIIB) in Q3 2024, closing a stake of 962 shares — an estimated $223K sold.

Summit Global Investments first reported a position in BIIB in Q4 2017 and held it in 14 quarters. The position peaked at $9.55M in Q4 2017. 917 funds tracked by Wall St. Rank hold BIIB as of Q3 2024.

  • Summit Global Investments reported no remaining Biogen position as of Q3 2024 after selling out during the quarter.
  • Summit Global Investments sold 962 Biogen shares in Q3 2024, an estimated $223K.
  • Summit Global Investments first reported a position in Biogen in Q4 2017 and held it in 14 quarters.
  • Summit Global Investments's Biogen position peaked at $9.55M in Q4 2017.
  • 917 funds tracked by Wall St. Rank held Biogen as of Q3 2024.

Based on Summit Global Investments's 13F filing for Q3 2024, filed 31 Oct 2024.